Salman Akhtar

Cardiology

10105 Banburry Cross Dr Ste 130
Las Vegas, NV 89144

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Bioinformatics Approaches in Noncoding RNAs Research.

Bioinformatics Approaches in Noncoding RNAs Research.

Journal: Experientia supplementum (2012)

Published: January 01, 2026

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

Journal: Current medicinal chemistry

Published: November 12, 2025

Targeting PI3K/AKT signaling in NSCLC: Dual in silico and in vitro validation of Withanolide B as a potent AKT modulator.

Targeting PI3K/AKT signaling in NSCLC: Dual in silico and in vitro validation of Withanolide B as a potent AKT modulator.

Journal: Journal of ethnopharmacology

Published: September 30, 2025

The intervention of AI and ML generated Xenobots in the perspective of future technology: a review.

The intervention of AI and ML generated Xenobots in the perspective of future technology: a review.

Journal: Computational biology and chemistry

Published: May 04, 2025

SREBP-1 in obesity-induced breast cancer: mechanisms and therapeutic perspectives.

SREBP-1 in obesity-induced breast cancer: mechanisms and therapeutic perspectives.

Journal: Molecular biology reports

Published: April 13, 2025

Tumor Angiogenesis and EGFR-Mutated Cancers: Structural Insights, Mutation Dynamics, and Innovative Therapeutic Strategies.

Tumor Angiogenesis and EGFR-Mutated Cancers: Structural Insights, Mutation Dynamics, and Innovative Therapeutic Strategies.

Journal: Current topics in medicinal chemistry

Published: March 09, 2025

Deoxynojirimycin derivatives as potent α-glucosidase inhibitors: in silico ADMET evaluation, molecular dynamics and in vitro validation studies.

Deoxynojirimycin derivatives as potent α-glucosidase inhibitors: in silico ADMET evaluation, molecular dynamics and in vitro validation studies.

Journal: Molecular diversity

Published: March 07, 2025

Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review.

Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review.

Journal: Molecular biology reports

Published: January 04, 2025

Evaluation of selected indigenous spices- and herbs-derived small molecules as potential inhibitors of SREBP and its implications for breast cancer using MD simulations and MMPBSA calculations.

Evaluation of selected indigenous spices- and herbs-derived small molecules as potential inhibitors of SREBP and its implications for breast cancer using MD simulations and MMPBSA calculations.

Journal: Molecular diversity

Published: November 05, 2024

Correction: In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies.

Correction: In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies.

Journal: Cell biochemistry and biophysics

Published: August 28, 2024

Polydatin inhibits histone deacetylase 1 and shows an anti-angiogenic action in head and neck squamous cell carcinoma.

Polydatin inhibits histone deacetylase 1 and shows an anti-angiogenic action in head and neck squamous cell carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: July 28, 2024

In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies.

In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies.

Journal: Cell biochemistry and biophysics

Published: July 02, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026